Indeed, using different lung cancer models, we demonstrated that the DDX3X degrader J10 efficiently induces DDX3X degradation and exhibits significantly more anti-tumor effects in all in vivo models with less toxicity compared to RK-33. This evidence concerns the gene DDX3X and lung carcinoma.